Bevacizumab PARIS team Breast cancer P53 Prognosis Deep learning Quality of life Biomarker Ovarian cancer Migration Hepatocellular carcinoma Biomarkers Epidemiology Targeted therapy Cancer du sein Human Ionizing radiation Non-small cell lung cancer Radiomics Surgery Prostate cancer Humans Carcinoma Macrophages Dendritic cells COVID-19 Actin Therapy NSCLC Mutation MRI Diagnosis Neoplasms Classification Apoptosis Immunotherapy Hypoxia Immune checkpoint inhibitors Survival Cancer Mortality Tumor microenvironment Colorectal cancer Gene expression Toxicity Lymphoma PET Radiotherapy Radiation therapy Metastasis Aging Leukemia Animals Bladder cancer Transcription Exosomes Adult Machine learning Medicine Artificial intelligence Angiogenesis Clinical trial Metabolism Mouse Cervical cancer Development Male Melanoma Genetics Cell migration Liver Cytoskeleton Autophagy Female Inflammation DNA repair Genomics Obesity Guidelines Chromatin France Glioblastoma Chemotherapy Lung cancer Homologous recombination Oxidative stress Oncology Mitochondria Aged Microfluidics Precision medicine Overall survival Middle Aged Tumor Dosimetry Recurrence Resistance Radiothérapie Head and neck cancer Epigenetics